Evidence Mounts for Effectiveness of National HPV Vaccine Program
Three doses of the quadrivalent HPV vaccine was more effective in preventing high-grade cervical abnormalities than other types and more effective in younger women.
SUBSCRIBE: eNewsletter
Three doses of the quadrivalent HPV vaccine was more effective in preventing high-grade cervical abnormalities than other types and more effective in younger women.
A highly specific rapid test for Chlamydia trachomatis has been developed. The best part: the new test requires a direct urine sample only (no total DNA purification needed).
A recent discovery suggests that Trichomonas vaginalis may alter the vaginal microbiota in a manner that cultivates bacteria that is beneficial to its survival and transmissibility.
Human papillomavirus (HPV) vaccination may be beneficial for women with HIV infection even after previous exposure to HPV, according to the findings of a new study.
According to the American Medical Association, the southern part of the United States is facing an HIV epidemic. Do you proactively talk with your patients about their risk of contracting HIV?
The number of cases of cephalosporin-resistant gonorrhea is increasing, according to a recent report issued by the World Health Organization. Neisseria gonorrhoeae, the bacteria that causes the infection, has already developed resistance to other common antibiotics, and cephalosporins have become the last line of defense against the infection.
Women over the age of 25 may still need to be screened for Chlamydia trachomatis (CT) according to research released at the American Congress of Obstetricians and Gynecologists’ (ACOG) Annual Clinical Meeting.
You have a patient with recurrent vaginal candidiasis and have tried everything you can think of!
According to research published in the Annals of Family Medicine, midstream urine testing effectively detects Chlamydia trachomatis.
Although previous studies of a new genital herpes vaccine were encouraging, it failed to protect women in a recent large clinical trial.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.